a day ago
Trending Stocks By Analyst's for this Week
Analyst Ratings (USA)
Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00. AbbVie received a Buy rating from Morgan Stanley, with a price target of $250.00. Aemetis had its target raised by UBS Group, reaffirming a Buy rating and lifting the price from $2.20 to $3.00. AeroVironment was initiated with a Buy rating by The Goldman Sachs Group, targeting $301.00. Affirm had its target raised by Barclays and maintained an Overweight rating, with the price increased from $67.00 to $80.00. Agnico Eagle Mines received an Outperform initiation from Raymond James Financial, with a target price of $130.00. Agree Realty was reiterated as Market Perform by JMP Securities. Air Products and Chemicals was reiterated with a Buy rating by Citigroup, increasing the target from $310.00 to $320.00. Alnylam Pharmaceuticals had its target raised by Wells Fargo & Company, maintaining an Equal Weight rating, and the price increased from $287.00 to $333.00. American Healthcare REIT was initiated at Sector Outperform by Scotiabank, with a target of $42.00. Amgen received a Buy rating from TD Cowen, with a price target of $389.00. Amgen was rated Hold by Morgan Stanley, with a target of $330.00. Amplify Energy was initiated with a Buy rating by Alliance Global Partners, with a price target of $6.00. Anglogold Ashanti PLC received a Buy rating from Roth MKM, with a target price of $54.00. Antero Resources was rated Hold by Citi, with a target of $45.00. Aramark was maintained at Equal Weight by Morgan Stanley, with a price target increase from $42.00 to $44.00. Argenx Se also received a Buy rating from Wells Fargo, targeting $741.00. Argenx Se was rated Buy by Citi, with a target price of $803.00. ARM had its target raised by Guggenheim, keeping a Buy rating and lifting the price from $147.00 to $187.00. Aurinia Pharmaceuticals was rated Buy by both Leerink Partners and TD Cowen, with targets of $10.00 and $11.00, respectively. Aytu BioPharma was given a Buy initiation by Ascendiant Capital Markets, with a target price of $12.00. B2Gold was initiated with an Outperform rating by Raymond James Financial, targeting $4.50. Baker Hughes Company was rated Buy by Wells Fargo, aiming for $50.00. Beazer Homes USA was initiated as Neutral by B. Riley, with a target of $23.00. BioCryst Pharmaceuticals had its Outperform rating reiterated by Royal Bank of Canada, with a target of $13.00. BioCryst received a Buy rating from BofA Securities, with a target of $15.00. Boeing was rated Buy by Citi, with a price target of $220.00. Boyd Gaming had its Outperform rating reaffirmed by Raymond James Financial, and its target raised from $81.00 to $85.00. BridgeBio Pharma had its target raised by Wells Fargo & Company, keeping an Overweight rating and raising the price from $67.00 to $76.00. BridgeBio Pharma received a Buy rating from Raymond James, with a price target of $57.00. Brookfield Asset Management was initiated with a Neutral rating by Piper Sandler, targeting $60.00. CAE was initiated with a Buy rating by The Goldman Sachs Group, with a target of $33.00. Candel Therapeutics received a Buy initiation from HC Wainwright, targeting $23.00. Capricor Therapeutics was initiated at Buy by Alliance Global Partners, with a price target of $20.00. CarMax received a Buy rating from Morgan Stanley, with a price target of $80.00. Celcuity had its Buy rating reiterated by Needham & Company LLC, with a target of $29.00. Celcuity received a Buy rating from LifeSci Capital, with a target of $27.00. Cencora was rated Hold by Jefferies Financial Group, with a raised target of $300.00. Century Communities was initiated with a Buy rating by B. Riley, targeting $70.00. Chemed had its Buy rating maintained by Bank of America, though the price target was lowered from $708.00 to $650.00. Cidara Therapeutics had its Market Outperform rating reiterated by JMP Securities, with a target of $59.00. Circle Internet Group was rated Buy by Canaccord Genuity Group, with a target price of $247.00. Circle Internet Group was rated Buy by Citigroup, with a target price of $243.00. Circle Internet Group was rated Buy by Needham & Company LLC, with a target price of $250.00. Circle Internet Group was rated Hold by Deutsche Bank Aktiengesellschaft, with a target price of $155.00. Circle Internet Group was rated Market Perform by Oppenheimer (no price target provided). Circle Internet Group was rated Neutral by The Goldman Sachs Group, with a target price of $83.00. Circle Internet Group was rated Outperform by Sanford C. Bernstein, with a target price of $230.00. Circle Internet Group was rated Overweight by Barclays, with a target price of $215.00. Circle Internet Group was rated Underweight by JPMorgan Chase & Co., with a target price of $80.00. Citius Pharmaceuticals was rated Buy by D. Boral Capital, with a target of $6.00. Clene was rated Buy by D. Boral Capital, with a target price of $23.00. Cloudastructure received a Buy rating from Maxim Group, targeting $6.00. Coeur Mining was rated Buy by Roth MKM, with a target price of $12.00. Cogent Biosciences was rated Neutral by Wedbush, targeting $10.00. Cohen & Steers was initiated with an Underperform rating by Bank of America, targeting $67.00. Comfort Systems USA was rated Buy by DA Davidson, and the price target was raised to $630.00. Concentrix was rated Buy by Canaccord Genuity Group, with a price target of $80.00. Consolidated Edison was upgraded to Outperform by Mizuho, with a target of $107.00. CoreCivic received a Buy rating from Texas Capital Securities, targeting $28.00. CorMedix was downgraded to Hold by D. Boral Capital (no new price target provided). Crocs was rated Buy by Bank of America, with a reduced target of $135.00. CVS Health was rated Buy by Jefferies Financial Group, with a new target of $80.00. Dave was rated Buy by Benchmark, with a raised price target of $320.00. Dayforce was rated Buy by Needham & Company LLC, targeting $95.00. Delek US was rated Outperform by Raymond James Financial, with a price target of $23.00. Dianthus Therapeutics was assigned a Buy rating by LifeSci Capital, with a target of $45.00. DoorDash was rated Outperform by Oppenheimer, targeting $280.00. Driven Brands was initiated as Buy by BTIG Research, targeting $22.00. Duolingo was rated Buy by Evercore ISI, targeting $540.00. Dutch Bros was initiated as Outperform by CICC Research, targeting $80.00. eBay was rated Equal Weight by Wells Fargo & Company, with a new target of $66.00. Edgewise Therapeutics was initiated with a Buy rating by HC Wainwright, with a price target of $42.00. Emerson Electric Company received a Buy rating from KeyBanc, with a price target of $155.00. Etsy was rated Underweight by Wells Fargo & Company, with a raised target of $41.00. Exelixis was rated Buy by HC Wainwright, with a revised target of $53.00. Expand Energy also received a Buy rating from Mizuho Securities, with a target of $142.00. Expand Energy received a Buy rating from Citi, targeting $140.00. Expeditors International of Washington was rated Hold by Truist Financial, with a revised target of $110.00. Expro Group Holdings received a Buy rating from Wells Fargo, with a target price of $12.00. Fabrinet was rated Buy by Fox Advisors, with a target of $335.00. Federal Signal was rated Outperform by Raymond James Financial, with a raised target of $120.00. First Busey was initiated as Market Perform by Hovde Group, with a target of $25.00. First Solar received a Buy rating from Wells Fargo, with a price target of $177.00. Frequency Electronics received a Buy rating from Freedom Capital Markets, targeting $27.00. Fulcrum Therapeutics was rated Sell by BofA Securities, with a price target of $6.00. Gain Therapeutics received a Buy rating from BTIG, with a price target of $10.00. Gain Therapeutics was rated Buy by Roth MKM, with a target price of $7.00. GeneDx was rated Buy by Guggenheim, with an increased target of $115.00. Genius Sports was rated Market Outperform by JMP Securities, with a raised price target of $13.00. Genpact received a Buy rating from Needham & Company LLC, targeting $50.00. Geo Group was also rated Buy by Texas Capital Securities, with a target of $30.00. Green Brick Partners was initiated with a Neutral rating by B. Riley, with a target of $62.00. Grindr received a Market Outperform rating from JMP Securities, with a raised target of $27.00. Guaranty Bancshares was rated Overweight by Stephens, targeting $47.00. GXO Logistics was rated Hold by Truist Financial, with a revised target of $48.00. Hewlett Packard Enterprise received a Buy rating from Bank of America, with a raised target of $23.00. Hippo Holdings was rated Buy by Financial, with a price target of $35.00. Home Depot received a Buy rating from Citi, aiming for $433.00. Home Depot received a Buy rating from Wells Fargo, with a price target of $420.00. Home Depot was rated Outperform by Telsey Advisory Group, targeting $455.00. Howmet Aerospace was rated Outperform by Royal Bank Of Canada. Hyatt Hotels also received a Buy rating from BofA Securities, targeting $150.00. Hyatt Hotels received a Hold rating from Morgan Stanley, targeting $132.00. Hyatt Hotels was rated Buy by Bernstein, targeting $167.00. Iamgold was initiated with a Market Perform rating by Raymond James Financial, targeting $8.00. Indivior was rated Buy by Craig Hallum, with a raised target of $22.00. Inmune Bio was rated Hold by BTIG, with a price target of $21.00. Inuvo received a Buy rating from HC Wainwright, with a target raised to $15.00. Ionis Pharmaceuticals was rated Buy by Barclays, targeting $57.00. It also received a target raise from Wedbush, maintaining the Outperform rating and increasing the price from $16.00 to $18.00. J.B. Hunt Transport Services was rated Hold by Truist Financial, with a new price target of $140.00. Joby Aviation was rated Buy by Canaccord Genuity, with a target of $12.00. KB Home received a Sell rating from CFRA, with a price target of $49.00. Kellanova received a Hold rating from TD Cowen, with a price target of $83.50. Kinross Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $15.00. KKR & Co. Inc. was initiated with an Overweight rating by Piper Sandler, targeting $150.00. Kratos Defense & Security Solutions was upgraded to Buy by The Goldman Sachs Group, targeting $52.00. Krystal Biotech was rated Buy by Clear Street, with a target of $190.00. Largo received a Buy rating from HC Wainwright, targeting $3.70. Lear was rated Buy by Citigroup, with a raised target of $136.00. Leonardo DRS was initiated as Buy by The Goldman Sachs Group, with a target of $49.00. Linde was upgraded to Buy by Citigroup, with a raised target of $535.00. M&T Bank was assigned a Buy rating by RBC Capital, with a target of $200.00. Marathon Petroleum was rated Strong-Buy by Raymond James Financial, with a raised target of $188.00. MasTec was rated Buy by Roth MKM, with a target of $210.00. McDonald's was rated Overweight by KeyCorp, with a revised price target of $325.00. McEwen Mining received a Buy rating from Roth MKM, with a target of $15.00. Medical Properties Trust was rated Sector Perform by Royal Bank Of Canada, with a lowered target of $4.50. Medtronic was upgraded to Peer Perform by Wolfe Research. Microsoft was reiterated with a Positive rating by UBS Group. Mister Car Wash was initiated with a Neutral rating by BTIG Research. Moderna received a Hold rating from Morgan Stanley, targeting $31.00. Neogen was rated Buy by Guggenheim, with a revised target of $10.00. New Gold was initiated with a Market Perform rating by Raymond James Financial, targeting $4.00. Norwegian Cruise Line was rated Neutral by UBS Group, with a reduced price target of $23.00. NOV also received a Hold rating from Citi, targeting $13.00. NOV was rated Sell by Wells Fargo, with a target of $10.00. NU received an Overweight rating from JPMorgan Chase & Co., with a raised target of $16.00. Nuvalent was rated Buy by Goldman Sachs, targeting $105.00. Old Dominion Freight Line was rated Buy by Truist Financial, with an updated target of $180.00. Omeros received a Buy rating from D. Boral Capital, targeting $36.00. Omnicell was rated Buy by Wells Fargo, with a target of $37.00. Oracle also received a Buy rating from TD Cowen, targeting $250.00. Oracle received a Buy rating from Deutsche Bank, with a target of $240.00. Oracle was upgraded to Buy by Stifel Nicolaus, with a target raised to $250.00. OS Therapies was rated Buy by D. Boral Capital, with a target of $20.00. Palomar was rated Outperform by Keefe, Bruyette & Woods, with a revised target of $204.00. Par Pacific received an Outperform rating from Raymond James Financial, with a raised price target of $30.00. Parker Hannifin received a Buy rating from BofA Securities, with a target of $715.00. Pegasystems was rated Buy by Loop Capital, with an increased price target of $60.00. Planet Labs PBC was initiated with a Neutral rating by The Goldman Sachs Group, targeting $4.60. PNC Financial received a Buy rating from RBC Capital, aiming for $195.00. Porch Group received a Buy rating from Financial, targeting $15.00. ProKidney was downgraded to Underperform by Bank of America, with a lowered target of $1.00. Protagonist Therapeutics received a Buy rating from Citi, with a price target of $72.00. Qorvo was also rated Hold by Mizuho Securities, targeting $84.00. Regeneron Pharmaceuticals was downgraded to Hold by Argus. Robinhood Markets received a Buy rating from KeyBanc, targeting $110.00. Robinhood Markets was rated Buy by Barclays, targeting $57.00. Roblox received an Overweight rating from JPMorgan Chase & Co., with a raised target of $120.00. Rocket Lab was initiated with a Neutral rating by The Goldman Sachs Group, targeting $27.00. Rocket Pharmaceuticals received a Hold rating from Morgan Stanley, with a target of $7.00. SailPoint was initiated with an Overweight rating by Cantor Fitzgerald, targeting $29.00. Schlumberger received an Overweight rating from JPMorgan Chase & Co., with a lowered target of $44.00. Schlumberger was rated Buy by Wells Fargo, targeting $43.00. SEI Investments was rated Outperform by Oppenheimer, with a raised target of $96.00. SharkNinja, Inc. was rated Buy by Jefferies, with a target of $175.00. Skyworks Solutions received a Hold rating from Mizuho Securities, with a target of $75.00. Smurfit Westrock received an Overweight rating from Barclays, with a slightly lowered target of $63.00. Southern Copper received a Hold rating from UBS, with a price target of $105.00. Starbucks was initiated with an Outperform rating by CICC Research, targeting $100.00. Stevanato Group was reiterated as Outperform by William Blair. Strategy was rated Buy by TD Cowen, targeting $590.00. Summit Therapeutics received a Buy rating from UBS, with a target of $30.00. Synopsys received a Hold rating from Wells Fargo, with a price target of $520.00. TD SYNNEX was rated Buy by Loop Capital, with an increased target of $160.00. Tempus AI was rated Buy by Guggenheim, with a raised target of $75.00. Tesla received a Buy rating from Deutsche Bank, with a price target of $345.00. Tesla was rated Buy by Morgan Stanley, with a price target of $410.00. Tesla was reiterated as Buy by Canaccord Genuity Group, with a target of $303.00. Transdigm Group was rated Buy by BofA Securities, with a price target of $1,615.00. Tronox was downgraded to Underperform by BMO Capital Markets, with a reduced target of $3.00. Tyra Bioscience was rated Buy by Oppenheimer, targeting $30.00. Unifirst received a target price of $197.00 set by Robert W. Baird. Unifirst was rated Underweight by Barclays, with a price target of $152.00. Unifirst was reiterated as Neutral by UBS Group. United Therapeutics was rated Buy by UBS Group, with a lowered target of $385.00. US Bancorp was rated Buy by RBC Capital, with a price target of $50.00. US Gold was assigned a Buy rating by Roth MKM, aiming for $18.00. Valero Energy was rated Strong-Buy by Raymond James Financial, with a raised target of $155.00. Vipshop received an Overweight rating from JPMorgan Chase & Co., with a decreased target of $18.00. Vipshop was given a Hold rating by Citi, with a target of $17.00. Virgin Galactic was initiated with a Neutral rating by The Goldman Sachs Group, targeting $3.00. Vor Biopharma was upgraded to Buy by HC Wainwright, targeting $3.00. Wabash National received a Hold rating from D.A. Davidson, with a target of $9.50. Walt Disney was upgraded to Buy by Jefferies Financial Group, with a target of $144.00. Waystar was initiated with an Outperform rating by Mizuho, targeting $48.00. Whirlpool was upgraded to Buy by Longbow Research, targeting $145.00. Wingstop was rated Buy by BTIG, with a target of $430.00. Winnebago Industries was rated Buy by Benchmark, with a reduced price target of $42.00. XPO was rated Buy by Truist Financial, with a raised target of $135.00. Zai Lab received an Outperform rating from Leerink Partners, with a revised target of $75.00. Zai Lab was assigned a Buy rating by Citi, with a target of $66.00. Zai Lab was rated Buy by Leerink Partners, with a price target of $75.00. Zynex was reiterated as Buy by HC Wainwright, targeting $8.00.
